Exfoliative Dermatitis Clinical Presentation
- Author: Therese I McBride, DO; Chief Editor: Barry E Brenner, MD, PhD, FACEP more...
History
- Prior dermatologic illnesses[1]
- Treatment with new medications
- Underlying systemic diseases
- Swelling or adenopathy
- Recurrent infections
- Cough or change in bowel or urinary habits
- Constitutional symptoms of low-grade fever, chills, and malaise (more commonly, patients complain of skin erythema, tightness, and scaling)
Physical
- Gynecomastia is a common finding in almost all patients with exfoliative dermatitis of several weeks' duration; it is believed to be secondary to hyperestrogenism, but the precise mechanism is unknown.
- Additional findings include alopecia, dystrophic nails, and hypopigmentation and/or hyperpigmentation.
- More than 40% of patients were febrile, with temperatures higher than 38°C; a relative tachycardia also was noted.
- Firm, rubbery lymphadenopathy, referred to as dermatopathic lymphadenitis, is a common finding.
- Hepatomegaly was noted in more than 50% of patients in one series, and splenomegaly was noted in approximately 30% of patients, all of whom had lymphoma.
- Steatorrhea may develop and tends to resolve when exfoliative dermatitis clears.
- Patients with exfoliative dermatitis have increased cutaneous blood flow, transcutaneous fluid losses, and radiation and convective heat losses.
- A number of cases of hypothermia have been reported.
- Fluid shifts increase cardiac output, causing dyspnea, dependent edema, and cardiac failure (possibly) in some patients.
- Prostate or thyroid glands may be enlarged or nodular.
Causes
- Systemic diseases (10-40%)
- Lymphoma - Primarily cutaneous T-cell lymphoma (CTCL)
- Leukemia
- Multiple myeloma
- Carcinoma of the lung, prostate, colon, and thyroid
- Graft versus host disease
- Immunodeficiency, including HIV
- Hodgkin disease
- Cutaneous diseases (10-40%)
- Drugs (3-10%)
- Dimercaprol (British antilewisite [BAL])
- Codeine
- Captopril
- Diphenylhydantoin
- Gold
- Iodine
- Antimicrobials - Sulfas, penicillin (PCN), cephalosporins, minocycline, isoniazid
- Granulocyte colony-stimulating factor (GCSF)
- Phenytoin
- Allopurinol
- Mercury
- Arsenic
- Quinidine
- Barbiturates
- Trimethadione
- Aspirin
- Carbamazepine
- Idiopathic (15-45%)
Okoduwa C, Lambert WC, Schwartz RA, Kubeyinje E, Eitokpah A, Sinha S, et al. Erythroderma: review of a potentially life-threatening dermatosis. Indian J Dermatol. 2009;54(1):1-6. [Medline].
Querfeld C, Guitart J, Kuzel TM, Rosen S. Successful treatment of recalcitrant, erythroderma-associated pruritus with etanercept. Arch Dermatol. Dec 2004;140(12):1539-40. [Medline].
Abrahams I, McCarthy JT, Sanders SL. 101 cases of exfoliative dermatitis. Arch Dermatol. Jan 1963;87:96-101. [Medline].
Adams JE, Mali JW, Karger AG, eds. Exfoliative dermatitis (erythroderma). Curr Probl Dermatol. 1972;4.
Bolognia JL, Braverman IM. Skin manifestations of internal disease. In: Harrison's Principles of Internal Medicine. 14th ed. 1998:310-312.
Brady WJ, DeBehnke DJ. Generalized skin disorders. In: Emergency Medicine A Comprehensive Study Guide. 5th ed. 2000:1594-1603.
Freedberg I, Baden H. Dermatology in general medicine. In: Textbook and Atlas. Vol 1. 1987:502.
Karakayli G, Beckham G, Orengo I, Rosen T. Exfoliative dermatitis. Am Fam Physician. Feb 1 1999;59(3):625-30. [Medline].
McKenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin North Am. Aug 2004;24(3):399-423, vi. [Medline].
Morar N, Dlova N, Gupta AK, Naidoo DK, Aboobaker J, Ramdial PK. Erythroderma: a comparison between HIV positive and negative patients. Int J Dermatol. Dec 1999;38(12):895-900. [Medline].
Moschella S, Hurley H. Dermatology. 2nd ed. 1985:543.
Nicolis GD, Helwig EB. Exfoliative dermatitis. A clinicopathologic study of 135 cases. Arch Dermatol. Dec 1973;108(6):788-97. [Medline].
Pruszkowski A, Bodemer C, Fraitag S, Teillac-Hamel D, Amoric JC, de Prost Y. Neonatal and infantile erythrodermas: a retrospective study of 51 patients. Arch Dermatol. Jul 2000;136(7):875-80. [Medline].
Quiceno GA, Cush JJ. Iatrogenic rheumatic syndromes in the elderly. Clin Geriatr Med. Aug 2005;21(3):577-88, vii. [Medline].
Rothe MJ, Bialy TL, Grant-Kels JM. Erythroderma. Dermatol Clin. Jul 2000;18(3):405-15. [Medline].
Shuster S, Brown JB. Gynaecomastia and urinary oestrogens in patients with generalised skin disease. Lancet. Dec 29 1962;2:1358. [Medline].
Sommer S, Henderson CA. Papuloerythroderma of Ofuji responding to treatment with cyclosporin. Clin Exp Dermatol. Jun 2000;25(4):293-5. [Medline].
Voigt GC, Kronthal HL, Crounse RG. Cardiac output in erythrodermic skin disease. Am Heart J. Nov 1966;72(5):615-20. [Medline].
Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin North Am. Aug 2004;24(3):357-71, v. [Medline].
Wilson HT. Exfoliative dermatitis; its etiology and prognosis. AMA Arch Derm Syphilol. May 1954;69(5):577-88. [Medline].

